Surgery Partners (SGRY) Capital Expenditures (2014 - 2026)

Surgery Partners' Capital Expenditures history runs 13 years deep, the most recent figure standing at $16.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 29.52% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $72.0 million (down 21.82% YoY), while the FY2025 annual figure was $78.7 million, down 12.94% from the prior year.
• Capital Expenditures came in at $16.0 million for Q1 2026 at Surgery Partners, up from $12.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $26.9 million in Q2 2024 to a low of $12.8 million in Q4 2025.
• A 5-year average of $20.9 million and a median of $21.0 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 65.93% in 2022 and plunged 42.6% in 2025, its largest moves.
• Surgery Partners' Capital Expenditures stood at $22.7 million in 2022, then dropped by 12.78% to $19.8 million in 2023, then advanced by 12.63% to $22.3 million in 2024, then slumped by 42.6% to $12.8 million in 2025, then advanced by 25.0% to $16.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $16.0 million, $12.8 million, and $19.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison